Ginkgo Bioworks Announces Participation in Upcoming Conferences
Ginkgo Bioworks (NYSE: DNA) announced its participation in several upcoming conferences aimed at showcasing its cell programming platform.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) announced its participation in several upcoming conferences aimed at showcasing its cell programming platform. The events include the Piper Sandler Annual Healthcare Conference on November 30, 2021, the Jefferies Alternative Protein & Related ESG Summit on December 1, 2021, and the Goldman Sachs Byte-ology Conference on December 9, 2021. More details, including webcast links and replays, will be available on their investor relations website.
Details
News Market Reaction – DNA
The recorded move for DNA in the trading session of this news was -0.83%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Nov. 24, 2021 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences:
- Piper Sandler Annual Healthcare Conference on Tuesday, November 30, 2021
- Jefferies Alternative Protein & Related ESG Summit on Wednesday, December 1, 2021 at 6:30 p.m. ET
- Goldman Sachs Byte-ology: The Convergence of Biotechnology and Technology Conference on Thursday, December 9, 2021 at 11:00 a.m. ET
Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-upcoming-conferences-301431387.html
SOURCE Ginkgo Bioworks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.